Status:

TERMINATED

Assessment Study to Evaluate Specific Immune Response in Locally Advanced Cervix Cancer After Radio-chemotherapy

Lead Sponsor:

Institut du Cancer de Montpellier - Val d'Aurelle

Conditions:

Cervical Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE2

Brief Summary

Perspectives: * To set-up another clinical trial with this specific phenotype as the main stratification factor. Therefore a more aggressive or a more specific systemic treatment (with or without an ...

Detailed Description

Cervical cancer is a real worldwide health care issue. High-risk human papillomavirus (HR-HPV) chronic infection is a co-factor in the development of the cervical cancer. The HR-HPV genome encodes tw...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years.
  • HPV-positive cervical cancer proven\* by biopsy.
  • All FIGO stages cervical cancers which are the matter for radio-chemotherapy and exclusive brachytherapy indications.
  • ECOG performance status ≤2.
  • Ability to give informed consent.
  • Patients must be affiliated to a Social Security System.
  • Patient information and written informed consent form signed.

Exclusion

  • Adenocarcinoma of cervix.
  • Known autoimmune disorder.
  • History of HIV and/ or hepatitis infection.
  • History of pelvic radiation or radio-chemotherapy.
  • Recurrent or metastatic cervical cancer.
  • Contra-indication for cisplatin.
  • Patient pregnant and/or breastfeeding.
  • History of other malignancy within the previous 5 years (except for appropriately treated melanoma skin carcinoma).
  • Patients with psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule

Key Trial Info

Start Date :

July 15 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 23 2023

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT03255252

Start Date

July 15 2017

End Date

November 23 2023

Last Update

May 18 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Clinique Beausoleil

Montpellier, France, 34070

2

CHRU Montpellier

Montpellier, France, 34295

3

Moussin Aurore

Montpellier, France, 34298